| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |